Analyst Patrick Trucchio works at HCWAINWRIGHT and is focused on the Healthcare sector with 71 price targets and ratings documented since 2018 spanning on 13 stocks. Previously, Patrick Trucchio worked at BERENBERG. Analyst's average stock valuation to be materialised ratio is 33.33% with an average time for price targets to be met of 86.75 days.
Most recent stock forecast was given on ALT, Altimmune, Inc at 20-Jan-2023.
Patrick Trucchio best performing recommendations are on MNMD.
The best stock recommendation documented was for MNMD at 9/20/2022. The price target of $5 was fulfilled within 8 days with a profit of $2 (28.57%) receiving and performance score of 35.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
2
$-5.57 (-73.58%)
2
4 months 25 days ago
2/4 (50%)
$-2.67 (-30.99%)
367
Hold
12
$4.43 (58.52%)
13
8 months 25 days ago
1/5 (20%)
$6.97 (104.11%)
3
Sell
2.5
$-5.07 (-66.97%)
7
8 months 26 days ago
5/6 (83.33%)
$-13.16 (-24.75%)
194
Hold
6
$-1.57 (-20.74%)
10
8 months 27 days ago
5/6 (83.33%)
$1.22 (14.55%)
32
Sell
2
$-5.57 (-73.58%)
10 months 26 days ago
1/2 (50%)
$5.07 (-14.60%)
84
